Immunohematologic characteristics of infection-associated cerebral infarction

Stroke

Volumn 22, Issue 8, 1991, Pages 1004-1009

  Ameriso, Sebastian F ^a   Wong, Vicky L Y ^a   Quismorio, Francisco P ^a   Fisher, Mark ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anticardiolipin antibodies; Anticoagulants; Blood coagulation disorders; Cerebral infarction; Infection

Indexed keywords

CARDIOLIPIN ANTIBODY; FIBRIN; FIBRINOGEN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN INFARCTION; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOLOGY; INFECTION; MALE; PRIORITY JOURNAL;

ADULT; AGED; CARDIOLIPINS; CEREBRAL INFARCTION; FEMALE; FIBRIN; FIBRINOGEN; HUMAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INFECTION; MALE; MIDDLE AGE; PHOSPHOLIPIDS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025902098     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.22.8.1004     Document Type: Article

References (41)

1. Syrjanen J, Valtonen W, Iivanainen M, Kaste M, Huttunen JK: Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J 1988;296:1156-1160
2. Janaki S, Baruah JK, Jayaram SR, Saxena VK, Sharma SR, Gulati MS: Stroke in the young: A four-year study, 1968 to 1972. Stroke 1975;6:318-320
3. Ode B, Cronberg S: Infection and intracranial arterial thrombosis. Lancet 1976;2:863-864
4. Hindfelt B, Nilsson O: Brain infarction in young adults with particular reference to pathogenesis. Acta Neurol Scand 1977;55:145-157
5. Syrjanen J, Valtonen W, Iivanainen M, Hovi T, Malkawaki M, Makela PH: Association between cerebral infarction and increased serum bacterial antibody levels in young adults. Acta Neurol Scand 1986;73:273-278
6. Feinberg WM, Bruck DC, Ring ME, Corrigan JJ Jr: Hemostatic markers in acute stroke. Stroke 1989;20:592-597
7. Fisher M, Francis RB: Altered coagulation in cerebral ischemia: Platelet, thrombin, and plasmin activity. Arch Neurol 1990;47:1075-1079
8. Levine SR, Deegan MJ, Futrell N, Welch KMA: Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990;40:1181-1189
9. Brey RL, Hart RG, Sherman DG, Tegeler CH: Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990;40:1190-1196
10. Norris JW: Comment on “Study design of stroke treatments” [letter]. Stroke 1982;13:527-528
11. Stimmler MM, Quismorio FP, Me Gehee WG, Boyien T, Sharma OP: Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med 1989;149:1833-1835
12. Hesselvik JF, Blomback M, Brodin B, Mailer R: Coagulation, fibrinotysis, and kallikrein systems in sepsis: Relation to outcome. Crit Care Med 1989;17:724-733
13. Voss R, Matthias FR, Borkowski G, Reitz D: Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Br J Haematol 1990;75:99-105
14. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA: Interleukin-1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984;160:618- 623
15. Hallenbeck JM, Dutka AJ, Kochanek PM, Siren A, Pezeshkpour GH, Feuerstein G: Stroke risk factors prepare rat bra inste m tissues for modified local Shwaruman reaction. Stroke 1988;19:863-869
16. Conway EM, Bach R, Rosenberg RD, Konigsberg WH: Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thromb Res 1989;53:231-241
17. Bernard JT, Araeriso S, Kempf RA, Rosen P, Mitchell MS, Fisher M: Transient focal neurologic deficits complicating interleukin-2 therapy. Neurology 1990;40:154-155
18. Hunt FA, Rylatt DB, Hart RA, Bundesen PG: Serum crosslinked fibrin (XDP) and fibrinogen-fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systems. Br J Haematol 1985;60:715-722
19. Wilde JT, Kitchen S, Kinsey S, Greaves M, Preston FE: Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states. Br J Haematol 1989;71:65-70
20. Francis CW, Connaghan DG, Scott WL, Marder VJ: Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction. Circulation 1987;75:1170-1177
21. Suffredini AF, Harpel PC, Parrillo JE: Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989;320:1165-1172
22. Boerger LM, Morris PC, Thurnau GR, Esmon CT, Comp PC: Oral contraceptives and gender affect protein S status. Blood 1987;69:692-694
23. Sacco RL, Owen J, Mohr JP, Tatemtchi TK, Grossman BA: Free protein S deficiency: A possible association with cerebrovascular occlusion. Stroke 1989;20:1657-1661
24. Vaarala O, Palosuo T, Kleemola M, Aho K: Anticardiolipin response in acute infections. Clin Immunol ¡mtnunopathol 1986;41:8-15
25. Syrjanen J, Vaarala O, Iivanainen M, Palosuo T, Valtonen W, Aho K: Anticardiolipin response and its association with infections in young and middle-aged patients with cerebral infarction. Acta Neurol Scand 1988;78:38l-386
26. Hasselaar P, Derksen RHWM, Oosting JD, Blokzijl L, de Groot PG: Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expression of procoagulant activity by cultured endothelial cells. Thromb Haanost 1989;62:654-660
27. Schorer AE, Wickham NWR, Watson KV: Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation. BrJ Haematol 1989;71:399-407
28. Wihehnsen L, Svardsudd K, Korsan-Bengtsen K, Laisson B, Welin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-505
29. Kannel WB, Wolf PA, Castelli WP, D’Agostino RB: Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987;258:1183-1186
30. Stuart J: The acute-phase reaction and haematological stress syndrome in vascular disease. Int J Microcirc:Clin Exp 1984;3:115-129
31. Elliott FA, Buckell M: Fibrinogen changes in relation to cerebrovascular accidents. Neurology 1961;11:120-124
32. Grotta J, Ackerman R, Correia J, Fallick G, Chang J: Whole blood viscosity parameters and cerebral blood flow. Stroke 1982;13:296-301
33. Ameriso SF, Hill AP, Meiselman HJ, Fisher M: Correlates of middle cerebral artery blood velocity in the elderly. Stroke 1990;21:1579-1583
34. Ringelstein EB, Mauckner A, Schneider R, Sturm W, Doering W, Wolf S, Maurin N, Willmes K, Schlenker M, Bruckmann H, Eschenfelder V: Effects of enzymatic blood defibri nation in subcortical arteriosclerotic encephalopathy. J Neural Neurosurg Psychiatry 1988;51:1051-1057
35. Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y: Characteristics affecting fibrinorytic activity and plasma fibrinogen concentration. Br Med J 1979;1:153-156
36. Lee H, Nurden AT, Thomaidis A, Caen JP: Relationship between fibrinogen binding and the platelet glycoprotein deficiencies in Glanzmann’s thrombasthenia Type I and Type II. Br J Haematol 1981;48:47-57
37. Busto R, Dietrich WD, Globus MY-T, Valdes I, Scheinberg P, Ginsberg MD: Small differences in in traischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 1987;7:729-738
38. Minamisawa H, Smith ML, Siesjo BK: The effect of mild hyperthermia and hypothermia on brain damage following 5, 10, and 15 minutes of forebrain ischemia. Ann Neurol 1990;28:26-33
39. Ernst E, Matrai A, Paulsen F: Leukocyte rheology in recent stroke. Stroke 1987;18:59-62
40. Vasthare US, Heinel LA, Rosenwasser RH, Tuma RF: Leukocyte involvement in cerebral ischemia and reperfusion injury. Surg Neurol 1990-33:261-265
41. Hallenbeck JM, Dutka AJ: Background review and current concepts of reperfusion injury. Arch Neurol 1990;47:1245-1254